The Hidden Inflammatory Trigger: New UNC Research Links Dietary Oxalate to IBD Severity on September 20, 2026 Posted by
The Longevity Benchmark: Can You Still Perform These 3 Classic Strength Moves After 60? on September 20, 2026 Posted by
The Politicization of the Stethoscope: Is Medical Neutrality a Vanishing Virtue? on September 20, 2026 Posted by
The Silent Pandemic: Loneliness Linked to 871,000 Annual Deaths as Experts Call for a “Third Pillar” of Health on September 20, 2026 Posted by
The Hidden Neurobiology of Relapse: Why Abstinence Can Be a Double-Edged Sword in Alcohol Addiction on September 20, 2026 Posted by
Bridging the Gap: How a Two-Decade Partnership is Redefining Medical-Dental Collaboration in Sleep Medicine on September 20, 2026 Posted by
The Silent Epidemic: Understanding and Managing Bunions Through Targeted Foot Mechanics on September 20, 2026 Posted by
The Hidden Inflammatory Trigger: New UNC Research Links Dietary Oxalate to IBD Severity on September 20, 2026 Posted by
The Longevity Benchmark: Can You Still Perform These 3 Classic Strength Moves After 60? on September 20, 2026 Posted by
The Politicization of the Stethoscope: Is Medical Neutrality a Vanishing Virtue? on September 20, 2026 Posted by
The Silent Pandemic: Loneliness Linked to 871,000 Annual Deaths as Experts Call for a “Third Pillar” of Health on September 20, 2026 Posted by
Posted in Respiratory Health Grifols Advances Paradigm Shift in Alpha-1 Antitrypsin Deficiency Treatment with Phase 3 SWIFT-SC Trial Launch on July 9, 2026
Posted in Sleep Health Avecho Biotechnology Clears Critical Milestone in Phase III CBD Insomnia Trial on July 7, 2026
Posted in Sleep Health Breakthrough in Narcolepsy Treatment: Takeda’s Oveporexton Shows Promise in Phase 3 Clinical Trials on July 6, 2026
Posted in Medical Innovations Abivax Clears Key Safety Hurdle for Obefazimod as Phase 3 Malignancy Concerns Subside on July 3, 2026
Posted in Respiratory Health Breakthrough in Antifungal Therapy: Phase 3 OASIS Trial Validates Olorofim for Invasive Aspergillosis on June 25, 2026
Posted in Sleep Health A New Dawn for Narcolepsy: Takeda’s Oveporexton Shows Transformative Potential in Phase 3 Trials on June 24, 2026
Posted in Digital Health Tools A Psychedelic Paradigm Shift: Definium Therapeutics’ LSD-Based Therapy Clears Key Phase 3 Hurdle on June 22, 2026
Posted in Medical Innovations Clinical Ambiguity: Edgewise Therapeutics’ Phase 2 Heart Data Leaves Investors Divided on June 18, 2026
Posted in Medical Innovations Johnson & Johnson Bolsters Oncology Portfolio with Positive Phase 3 Data for Talvey Combination Therapy on June 16, 2026
Posted in Medical Innovations Eli Lilly’s New Myelofibrosis Candidate Challenges Incyte’s Market Dominance Following Strong Phase 1 Data on June 16, 2026
